España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Kenvue
KVUE
NYSE
Watchlist
Get Report
Perks
Buy
Compare Brokers
$18.11
-0.23
-1.25%
At Close: -
$18.11
0
0.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Get Report
Watch
Kenvue (KVUE) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Kenvue (NYSE:KVUE) Stock
Kenvue Stock (NYSE: KVUE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, July 11, 2024
Citigroup Maintains Neutral on Kenvue, Lowers...
Benzinga Newsdesk
Wednesday, June 26, 2024
Sanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC
Vandana Singh
Friday, June 07, 2024
Peering Into Kenvue's Recent Short Interest
Benzinga Insights
Thursday, May 30, 2024
Want Better Returns? Don't Ignore These 2 Consumer Staples Stocks Set to Beat Earnings
Zacks
Tuesday, May 28, 2024
Deep Dive Into Kenvue Stock: Analyst Perspectives (5 Ratings)
Benzinga Insights
Citigroup Reinstates Neutral on Kenvue, Annou...
Benzinga Newsdesk
Wednesday, May 22, 2024
Looking Into Kenvue's Recent Short Interest
Benzinga Insights
Thursday, May 16, 2024
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Upwallstreet
Tuesday, May 14, 2024
Kenvue Priced Secondary Offering Of 182.3M Sh...
Charles Gross
Monday, May 13, 2024
Kenvue shares are trading lower after the com...
Benzinga Newsdesk
Kenvue Announces Launch of Secondary Offering...
Benzinga Newsdesk
Kenvue Filed For Offering Of 182.3M Shares Of Common Stock By Selling Shareholders
Charles Gross
Wednesday, May 08, 2024
In-Depth Examination Of 7 Analyst Recommendations For Kenvue
Benzinga Insights
HSBC Maintains Hold on Kenvue, Raises Price T...
Benzinga Newsdesk
Tuesday, May 07, 2024
US Stocks Eye Fourth Positive Session Despite Hawkish Fed Remarks; Disney, Palantir Tumble; Treasury Yields Fall: What's Driving Markets Tuesday?
Piero Cingari
Band-Aid Maker Kenvue Cuts Workforce By 4%, Q1 Earnings Beat Street Expectations
Vandana Singh
Kenvue shares are trading higher following be...
Benzinga Newsdesk
Kenvue Continues To Expect Full Year 2024 Adj...
Benzinga Newsdesk
Kenvue Expects 2024 Reported Net Sales Growth...
Benzinga Newsdesk
Kenvue Q1 2024 Adj EPS $0.28 Beats $0.26 Esti...
Benzinga Newsdesk
Wednesday, April 24, 2024
Looking Into Kenvue's Recent Short Interest
Benzinga Insights
Tuesday, April 23, 2024
Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert (Updated)
Vandana Singh
Thursday, April 11, 2024
Kenvue shares are trading lower after Bernste...
Benzinga Newsdesk
Bernstein Initiates Coverage On Kenvue with U...
Benzinga Newsdesk
Wednesday, April 03, 2024
Beyond The Numbers: 5 Analysts Discuss Kenvue Stock
Benzinga Insights
William Blair Initiates Coverage On Kenvue wi...
Benzinga Newsdesk
Friday, March 29, 2024
How Is The Market Feeling About Kenvue?
Benzinga Insights
Wednesday, March 13, 2024
Looking Into Kenvue's Recent Short Interest
Benzinga Insights
Thursday, March 07, 2024
Watching Kenvue; Shares Spike Higher As Trade...
Benzinga Newsdesk
Monday, March 04, 2024
Goldman Sachs Maintains Neutral on Kenvue, Lo...
Benzinga Newsdesk
Friday, March 01, 2024
Goldman Sachs Downgrades Kenvue to Neutral, M...
Benzinga Newsdesk
Tuesday, February 13, 2024
RBC Capital Reiterates Outperform on Kenvue, ...
Benzinga Newsdesk
Friday, February 09, 2024
JP Morgan Maintains Overweight on Kenvue, Low...
Benzinga Newsdesk
RBC Capital Maintains Outperform on Kenvue, L...
Benzinga Newsdesk
Thursday, February 08, 2024
Why Is Consumer Health Firm Kenvue Stock Trading Lower Today?
Vandana Singh
Kenvue shares are trading lower after the com...
Benzinga Newsdesk
Kenvue Expects 2024 Reported Net Sales Growth...
Benzinga Newsdesk
Kenvue Q4 Adj EPS $0.31 Beats $0.28 Estimate,...
Benzinga Newsdesk
Earnings Scheduled For February 8, 2024
Benzinga Insights
Thursday, January 25, 2024
A Look Into Kenvue Inc's Price Over Earnings
Benzinga Insights
Monday, January 22, 2024
Johnson & Johnson's Q4 Earnings: Spotlight On Dividend Security Following Kenvue Split, Legal Costs, Acquisitions
Surbhi Jain
Friday, January 19, 2024
(KVUE) - Analyzing Kenvue's Short Interest
Benzinga Insights
Tuesday, December 26, 2023
Nasdaq Leads Over NYSE in IPO Listings, Drawing Major Tech and Global Firms in 2023
Nabaparna Bhattacharya
Wednesday, December 20, 2023
Judge Bars Testimony Linking Kenvue's Pain Killer Tylenol to Autism in Pregnancy
Vandana Singh
How To Earn $1,000 Per Month From Kenvue (NYSE: KVUE) Stock
Shankar Iyer
Tuesday, December 19, 2023
Kenvue Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Benzinga Insights
Kenvue shares are trading higher after UBS ma...
Benzinga Newsdesk
UBS Maintains Neutral on Kenvue, Raises Price...
Benzinga Newsdesk
Monday, December 18, 2023
12 Consumer Staples Stocks Moving In Monday's After-Market Session
Benzinga Insights
How Is The Market Feeling About Kenvue?
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch